Home › Funds › ALETHEA CAPITAL MANAGEMENT, LLC › AXSM
ALETHEA CAPITAL MANAGEMENT, LLC position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
ALETHEA CAPITAL MANAGEMENT, LLC reported holding 649,117 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$119.7M, representing 60.89% of its reported portfolio and ranking #1 among its reported holdings. ALETHEA CAPITAL MANAGEMENT, LLC has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ALETHEA CAPITAL MANAGEMENT, LLC's AXSM position evolved
ALETHEA CAPITAL MANAGEMENT, LLC first disclosed a stake in AXSM in Q3 2023 at 758,794 shares (US$53.0M). The position peaked in Q2 2026 at 648,756 shares, worth US$158.8M. Across 13 filings, ALETHEA CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 649,117 shares valued at US$119.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 758.79K | $53.03M | New |
| Q4 2023 | 752.04K | $59.86M | Reduce |
| Q1 2024 | 740.79K | $59.12M | Reduce |
| Q2 2024 | 740.89K | $59.64M | Hold |
| Q3 2024 | 738.50K | $66.37M | Hold |
| Q4 2024 | 734.32K | $62.13M | Reduce |
| Q1 2025 | 667.37K | $77.84M | Reduce |
| Q2 2025 | 667.37K | $69.67M | Hold |
| Q3 2025 | 670.88K | $81.48M | Add |
| Q4 2025 | 668.71K | $122.13M | Hold |
| Q1 2026 | 649.11K | $109.71M | Reduce |
| Q2 2026 | 648.76K | $158.80M | Hold |
| Q3 2026 | 649.12K | $119.69M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 49 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), Hood River Capital Management LLC (US$98.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$77.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K sh · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
- Cannell & Spears LLC 259.65K sh · $47.88M · Q3 2026
More on ALETHEA CAPITAL MANAGEMENT, LLC
FAQ
How long has ALETHEA CAPITAL MANAGEMENT, LLC held AXSM?
ALETHEA CAPITAL MANAGEMENT, LLC has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ALETHEA CAPITAL MANAGEMENT, LLC's current position in AXSM?
As of Q3 2026, ALETHEA CAPITAL MANAGEMENT, LLC holds 649.12K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $119.69M, representing 60.89% of its reported portfolio and ranking #1.
Has ALETHEA CAPITAL MANAGEMENT, LLC been buying or selling AXSM?
In the latest 13F filing (Q3 2026), ALETHEA CAPITAL MANAGEMENT, LLC held unchanged its position in AXSM. The position peaked in Q2 2026 at 648.76K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, Hood River Capital Management LLC, EVENTIDE ASSET MANAGEMENT, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.